Search Videos and More

Showing 1 - 12 of 226 results

Previous| 1 | 2 | 3 ...19 |Next


Updates in Urologic Oncology Symposium

Updates in Urologic Oncology

The First NCI-Designated Comprehensive Cancer Center Using 3D Genomics Testing to Diagnose Lymphoma and Sarcoma—a True Game Changer News

The First NCI-Designated Comprehensive Cancer Center Using 3D Genomics Testing to Diagnose Lymphoma and Sarcoma—a True Game Changer

Diagnosing lymphoma and sarcoma can be extraordinarily complex, with more than 70 recognized subtypes of lymphoma and more than 100 distinct types of sarcoma. Many subtypes share similar features yet behave in dramatically different ways in standard testing, leaving oncologists with diagnostic quandaries and delays to treatment.
Delivering Big Ideas from ASH 2025 News

Delivering Big Ideas from ASH 2025

At Fox Chase Cancer Center and Temple University Hospital, it’s “in the blood” of our residents and Fellows to develop innovative scientific ideas that significantly affect the way blood diseases are diagnosed and treated. Here is the latest from ASH 2025:
Fellowship Training That Goes Where You Go News

Fellowship Training That Goes Where You Go

As Chief Fellow Giuliana Berardi, MD, a third-year Hematology/Oncology Fellow at Fox Chase Cancer Center, reflected on her medical training, she noted the steep learning curve that accompanied each new level of medical training.
Preparing for the Routine and Unforeseen in the Urologic OR News

Preparing for the Routine and Unforeseen in the Urologic OR

From 11 am to 11 pm, Joon Park, MSHI, BSN, RN, CNOR, Fox Chase Cancer Center Perioperative Evening Charge Nurse, manages the surgical staff workflow and patient assignments for the Fox Chase Cancer operating room.
Fox Chase Fellows Shape the World of Cancer Care News

Fox Chase Fellows Shape the World of Cancer Care

Wherever they go, Fox Chase Fellows and residents bring a significant contribution to the world of cancer care, from distinguished JAMA peer reviews to notable advances in the field of neuroendocrine cancer to accolades for research, academy leadership, and compassionate clinical care.
Unconventional and Exceptional: Dr. Lee’s Fox Chase Residency News

Unconventional and Exceptional: Dr. Lee’s Fox Chase Residency

Peter L. Lee, MD, PhD, has two distinct and interesting roles in radiation oncology at the Mass General Brigham Cancer Institute: one as radiation oncologist specializing in GU cancers, and another as a leader tasked to develop the hospital’s Exercise Oncology Program –a rapidly growing specialty that focuses on the benefits of exercise for cancer management.
Defeating Cancer Means Never Resting on Our Laurels News

Defeating Cancer Means Never Resting on Our Laurels

At Fox Chase Cancer Center, our faculty, fellows, and residents always look to the future to develop and collaborate on therapeutic breakthroughs to enhance life and extend it—never resting on accolades earned in the past.
Temple Health Appoints Alex Khariton, MBA, as Chief Operating Officer of Fox Chase Cancer Center News

Temple Health Appoints Alex Khariton, MBA, as Chief Operating Officer of Fox Chase Cancer Center

Fox Chase Cancer Center (Fox Chase) and Temple Health today announced that Alex Khariton, MBA, has been appointed Chief Operating Officer of Fox Chase and Senior Vice President for Cancer Services across Temple Health effective February 23, 2026.
Comprehensive Urology Care for Advanced Practice Providers:<br>Mastering Inpatient and Outpatient Management Course

Comprehensive Urology Care for Advanced Practice Providers:
Mastering Inpatient and Outpatient Management

Date: Thursday, June 11, 2026 | 7:30 PM - 4:00 PM, Friday, June 12, 2026 | 7:30 AM - 5:00 PM
Study Finds Radiation Therapy Administered Before Surgery Rarely Shrinks Retroperitoneal Sarcoma Tumors News

Study Finds Radiation Therapy Administered Before Surgery Rarely Shrinks Retroperitoneal Sarcoma Tumors

According to new research from Fox Chase Cancer Center, radiation therapy administered before surgery rarely produces favorable responses in patients with retroperitoneal sarcoma (RPS), a rare and aggressive cancer that forms in the abdomen. The study reinforces findings from a major international clinical trial and suggests that, due to ineffectiveness, radiation should not be used to shrink tumors before surgery.
Home-Based Monitoring Could Transform Care for Patients Receiving T-Cell Redirecting Therapies News

Home-Based Monitoring Could Transform Care for Patients Receiving T-Cell Redirecting Therapies

A study found that outpatient observation cut hospital stays dramatically, with no adverse safety events reported. It also freed up inpatient beds and cut healthcare costs.

Showing 1 - 12 of 226 results

Previous| 1 | 2 | 3 ...19 |Next